PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
06-Feb-2024 ALTURiX Acquires UK Rights to Three New Products ALTURiX
06-Feb-2024 Original-Research: Cantourage Group SE (von NuWays AG) Cantourage Group SE
06-Feb-2024 APONTIS PHARMA successfully completes performance and efficiency improvement program APONTIS PHARMA AG
06-Feb-2024 Courts of Basel-Stadt have revoked bankruptcy of Kinarus Therapeutics Holding AG Kinarus Therapeutics Holding AG
05-Feb-2024 MorphoSys Enters into Business Combination Agreement to be Acquired by Novartis for € 2.7 Billion Equity Value MorphoSys AG
05-Feb-2024 Ad hoc: MorphoSys AG Enters into Business Combination Agreement to be Acquired by Novartis for € 2.7 Billion Equity Value and into Purchase Agreement with Incyte for the Sale of Tafasitamab MorphoSys AG
05-Feb-2024 Beiersdorf Aktiengesellschaft: Beiersdorf proposes to increase dividend for fiscal year 2023 and announces share buyback program Beiersdorf Aktiengesellschaft
05-Feb-2024 MPH Health Care AG sells 1.5 million shares in its investment M1 Kliniken AG to its Management Board members MPH Health Care AG
05-Feb-2024 Management Board of M1 Kliniken AG acquires 1.5 million shares in the company and plans an uplisting to the Prime Standard M1 Kliniken AG
05-Feb-2024 Xlife Sciences AG Expands Collaboration with Department of Health Abu Dhabi, Partners with Thermo Fisher Scientific and Masdar City Xlife Sciences AG
02-Feb-2024 Cannovum Cannabis AG: April 2024 starts the legalization of cannabis in Germany, enormous potential for sales and growth Cannovum Cannabis AG
02-Feb-2024 Abivax announces update to obefazimod Phase 2b clinical development program in moderately to severely active Crohn’s disease ABIVAX
02-Feb-2024 Medacta Group SA: Medacta Group SA revenues up +19.5% at constant currency1 exceeding the milestone of 500Mln € in FY 2023 Medacta Group SA
01-Feb-2024 PRODUCTLIFE GROUP ACQUIRES COMMERCIAL EYES, EXPANDING ITS FOOTPRINT IN THE APAC REGION PRODUCTLIFE GROUP
01-Feb-2024 Clinigen’s NaviGATE programme shows a third of rare disease patients are not aware that they can access unlicensed medicines Clinigen 
01-Feb-2024 Medios AG: Supervisory Board extends contracts with members of the Executive Board Mi-Young Miehler and Christoph Prußeit Medios AG
01-Feb-2024 DOUGLAS updates sustainability strategy with ambitious goals Douglas GmbH
01-Feb-2024 Kuros Biosciences to Present at the CG 2024 Musculoskeletal Conference Kuros Biosciences AG
31-Jan-2024 Vita 34 publishes preliminary figures on the course of business in 2023 Vita 34 AG
31-Jan-2024 Epigenomics AG: Supervisory Board of Epigenomics AG appoints Hansjörg Plaggemars as member of the Executive Board Epigenomics AG